132 related articles for article (PubMed ID: 38123060)
1. Exploring natural anthraquinones as potential MMP2 inhibitors: A computational study.
Jamshidi S; Rostami A; Shojaei S; Taherkhani A; Taherkhani H
Biosystems; 2024 Jan; 235():105103. PubMed ID: 38123060
[TBL] [Abstract][Full Text] [Related]
2. Potential JAK2 Inhibitors from Selected Natural Compounds: A Promising Approach for Complementary Therapy in Cancer Patients.
Vaziri-Amjad S; Rahgosha R; Taherkhani A
Evid Based Complement Alternat Med; 2024; 2024():1114928. PubMed ID: 38706884
[TBL] [Abstract][Full Text] [Related]
3. Ligand-based design of anticancer MMP2 inhibitors: a review.
Sanyal S; Amin SA; Adhikari N; Jha T
Future Med Chem; 2021 Nov; 13(22):1987-2013. PubMed ID: 34634916
[TBL] [Abstract][Full Text] [Related]
4. Naringin dihydrochalcone potentially binds to catalytic domain of matrix metalloproteinase-2: molecular docking, MM-GBSA, and molecular dynamics simulation approach.
Singh AK; Kumar S
Nat Prod Res; 2023 Jun; 37(11):1851-1855. PubMed ID: 36047975
[TBL] [Abstract][Full Text] [Related]
5. Anthraquinone metabolites isolated from the rhizosphere soil Streptomyces of Panax notoginseng (Burk.) F. H. Chen target MMP2 to inhibit cancer cell migration.
Xue JY; Wu YY; Han YL; Song XY; Zhang MY; Cheng J; Lin B; Xia MY; Zhang YX
J Ethnopharmacol; 2023 Aug; 312():116457. PubMed ID: 37088235
[TBL] [Abstract][Full Text] [Related]
6. Computational insights into the identification of a potent matrix metalloproteinase inhibitor from
Paramashivam S; Dhiraviam KN
3 Biotech; 2021 May; 11(5):206. PubMed ID: 33927994
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach.
Sharma A; Islam MH; Fatima N; Upadhyay TK; Khan MKA; Dwivedi UN; Sharma R
Mol Biol Rep; 2019 Apr; 46(2):1715-1725. PubMed ID: 30715689
[TBL] [Abstract][Full Text] [Related]
8. Scaffold-based Screening and Molecular Dynamics Simulation Study to Identify Two Structurally Related Phenolic Compounds as Potent MMP1 Inhibitors.
Patra S; Saravanan P; Das B; Subramanian V; Patra S
Comb Chem High Throughput Screen; 2020; 23(8):757-774. PubMed ID: 32342802
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Aryloxyphenyl-Heptapeptide Hybrids as Potent and Selective Matrix Metalloproteinase-2 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis.
Takeuchi T; Hayashi M; Tamita T; Nomura Y; Kojima N; Mitani A; Takeda T; Hitaka K; Kato Y; Kamitani M; Mima M; Toki H; Ohkubo M; Nozoe A; Kakinuma H
J Med Chem; 2022 Jun; 65(12):8493-8510. PubMed ID: 35687819
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase inhibitor and sunscreen effective compounds from Rumex crispus L.: isolation, identification, bioactivity and molecular docking study.
Uzun M; Guvenalp Z; Kazaz C; Demirezer LO
Phytochem Anal; 2020 Nov; 31(6):818-834. PubMed ID: 32488908
[TBL] [Abstract][Full Text] [Related]
11. In silico screening of anthraquinones from Prismatomeris memecyloides as novel phosphodiesterase type-5 inhibitors (PDE-5Is).
Khanh PN; Huong TT; Spiga O; Trezza A; Son NT; Cuong TD; Ha VT; Cuong NM
Rev Int Androl; 2018; 16(4):147-158. PubMed ID: 30286869
[TBL] [Abstract][Full Text] [Related]
12. Identification of highly potent and selective MMP2 inhibitors addressing the S1' subsite with d-proline-based compounds.
Lenci E; Innocenti R; Di Francescantonio T; Menchi G; Bianchini F; Contini A; Trabocchi A
Bioorg Med Chem; 2019 May; 27(9):1891-1902. PubMed ID: 30926311
[TBL] [Abstract][Full Text] [Related]
13. Cinnamic acid derivatives as potential matrix metalloproteinase-9 inhibitors: molecular docking and dynamics simulations.
Malekipour MH; Shirani F; Moradi S; Taherkhani A
Genomics Inform; 2023 Mar; 21(1):e9. PubMed ID: 37037467
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of four anthraquinones on tyrosinase activity: Insight from spectroscopic analysis and molecular docking.
Zeng HJ; Sun DQ; Chu SH; Zhang JJ; Hu GZ; Yang R
Int J Biol Macromol; 2020 Oct; 160():153-163. PubMed ID: 32464200
[TBL] [Abstract][Full Text] [Related]
15. Interaction of marine Streptomyces compounds with selected cancer drug target proteins by in silico molecular docking studies.
Lankapalli AR; Kannabiran K
Interdiscip Sci; 2013 Mar; 5(1):37-44. PubMed ID: 23605638
[TBL] [Abstract][Full Text] [Related]
16. Whey peptide Isoleucine-Tryptophan inhibits expression and activity of matrix metalloproteinase-2 in rat aorta.
Kopaliani I; Martin M; Zatschler B; Müller B; Deussen A
Peptides; 2016 Aug; 82():52-59. PubMed ID: 27239047
[TBL] [Abstract][Full Text] [Related]
17. Rhein Inhibits the Progression of Chemoresistant Lung Cancer Cell Lines via the Stat3/Snail/MMP2/MMP9 Pathway.
Liu J; Ding D; Liu F; Chen Y
Biomed Res Int; 2022; 2022():7184871. PubMed ID: 35178453
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of matrix metalloproteinases-2, -9, and -13 activities by selected anthraquinones.
Wierzchacz C; Su E; Kolander J; Gebhardt R
Planta Med; 2009 Mar; 75(4):327-9. PubMed ID: 19152226
[TBL] [Abstract][Full Text] [Related]
19. Selected anthraquinones as potential free radical scavengers and P-glycoprotein inhibitors.
Jeremić S; Amić A; Stanojević-Pirković M; Marković Z
Org Biomol Chem; 2018 Mar; 16(11):1890-1902. PubMed ID: 29479603
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel selective MMP-9 inhibitors as potential anti-metastatic lead using structure-based hierarchical virtual screening and molecular dynamics simulation.
Kalva S; Agrawal N; Skelton AA; Saleena LM
Mol Biosyst; 2016 Jul; 12(8):2519-31. PubMed ID: 27250644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
